# Efficacy and Safety of Levetiracetam in the Inpatient Treatment of Alcohol Withdrawal Syndrome

> **NCT00146471** · PHASE3 · COMPLETED · sponsor: **Charite University, Berlin, Germany** · enrollment: 120 (actual)

## Conditions studied

- Alcohol Withdrawal Syndrome

## Interventions

- **DRUG:** Levetiracetam
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00146471
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2007-07
- **Final completion:** 2007-09
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2009-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00146471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00146471, "Efficacy and Safety of Levetiracetam in the Inpatient Treatment of Alcohol Withdrawal Syndrome". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00146471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*